Cannabics Pharmaceuticals (OTCMKTS:CNBX) Cannabis Diagnostic Testing скачать в хорошем качестве

Cannabics Pharmaceuticals (OTCMKTS:CNBX) Cannabis Diagnostic Testing

Cannabics Pharmaceuticals (OTCMKTS:CNBX) CEO Eyal Barad discusses the company’s plans to collect data on cannabinoids and cancer to create diagnostic tools and treatments for the disease. Barad sees Cannabics’ data as especially useful for doctors who prescribe cannabis therapies to cancer patients. Cannabics plans to further commercialize its diagnostic testing products and develop additional palliative products for the cancer market. Cannabics intends to test its products and collect data in Israel, the United States, and Germany, but remains interested in the Canadian medical cannabis market. ************************ Check out our website: https://midasletter.com ************************ SUBSCRIBE to our YouTube: http://bit.ly/MidasLetterYoutube SUBSCRIBE to our Newsletter: http://bit.ly/MidasLetterNewsletter Download Our Podcast on iTunes: http://bit.ly/MidasLetterPodcast ************************ Follow Us on Twitter: http://bit.ly/MidasLetterTwitter Like Us on Instagram: http://bit.ly/MidasLetterInsta Like Us on Facebook: http://bit.ly/MidasLetterFacebook ************************ #Cannabics #Cancer #Cannabis